|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,503.00 INR | +1.66% |
|
+2.97% | +13.95% |
| 23/04 | CARE Ratings Assigns AA+ Rating to Mankind Pharma's Bank Facilities; Shares Up 3% | MT |
| 19/03 | Novo Nordisk patent expiry opens door to cheaper weight-loss drugs in India | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5d. change | Varia. Jan 1. | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MANKIND PHARMA LIMITED | Other Pharmaceuticals | +1.66% | +2.97% | +13.95% | -2.71% | - | 1.08TCr |  | |  |
- Stock Market
- Equities
- MANKIND Stock
- Charts Mankind Pharma Limited
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition